New Zealand’s health regulator Medsafe has approved the paediatric Pfizer vaccine against Covid-19 for children of age 5 to 12 years, the health ministry said in a statement.

• Zee Entertainment Faces NFRA Penalties
• Mangal Electrical Industries Files DRHP with SEBI to Raise 450 Crore 
• India’s Agriculture Export Policy to Go Under Review 
• Bitcoin Total Supply Down to its Last 1.2 Million 
• Stocks Under F&O Ban: RBL Bank

The temporary approval is for two doses of the paediatric Pfizer Covid-19 vaccine, which can be given in at least 21 days break, the statement said. If the cabinet approves the vaccine, the paediatric Pfizer vaccine will be started in New Zealand by the end of January 2022, the health ministry added.